Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.19 -0.15%   SPY: 166.93 -0.01%
Quote Spy AGEN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Agenus Inc (AGEN)

@ May-20
Click the portfolio to add AGEN:
Close [X]
+ Add AGEN to Portfolio
  
  Last Trade: $4.14 -0.11 (-2.59%)
  Volume: 104,457 39% of avg daily volume
       
  Avg Volume: 269,110
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 4.09 - 4.25
  Open: 4.24
  Previous Close: 4.25
  52-wk Range: 3.37 - 5.99
  Market Cap: 104.7M
  P/E: -3.7
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (-0.9%)
Spy AGEN

? Pro holders
? Member holders
? Items submitted
Additional AGEN resources



Customize Links
To see which Pros and tickerspy members own AGEN Sign up now
Latest AGEN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Positive Phase 2 Data from Agenus' Brain Cancer Vaccine Presented at Plenary Session of American Academy of Neurological Surgeons Meeting
AGEN  
Linked by GlobeNewswire - May 01, 11:43AM from (globenewswire.com)
LEXINGTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced that preliminary data from a  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Reports First Quarter 2013 Financial Results
AGEN  
Linked by GlobeNewswire - April 24, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 24, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow
AGEN  
Linked by GlobeNewswire - April 18, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 18, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its first quarter 2013 financial  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Eliminates Its $39 Million Senior Notes and Completes $10 Million of New Debt Financing
AGEN  
Linked by GlobeNewswire - April 16, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 16, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a leading developer of therapeutic vaccines  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus' Brain Cancer Vaccine Results to be Presented at Plenary Session of the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
AGEN  
Linked by GlobeNewswire - April 10, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 10, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today that Orin Bloch, MD, Clinical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Present at the ROTH Annual Conference
AGEN  
Linked by GlobeNewswire - March 14, 02:13PM from (globenewswire.com)
LEXINGTON, Mass., March 14, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Reports Fourth Quarter and Year End 2012 Financial Results
AGEN  
Linked by GlobeNewswire - February 28, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus' HerpV Phase 2 Study to Treat Genital Herpes Completes Enrollment
AGEN  
Linked by GlobeNewswire - February 27, 07:43AM from (globenewswire.com)

LEXINGTON, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Present at Cowen and Company Annual Healthcare Conference
AGEN  
Linked by GlobeNewswire - February 26, 09:13AM from (globenewswire.com)
LEXINGTON, Mass., Feb. 26, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Report Fourth Quarter and Year End 2012 Financial Results on February 28, 2013; Conference Call to Follow
AGEN  
Linked by GlobeNewswire - February 21, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its fourth quarter and year ended  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 12



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource